Houston-based Sesh Coworking has launched an online platform so that members can work alongside each other. Photo via seshcoworking.com

As the COVID-19 pandemic continued to enforce working from home and social distancing earlier this summer, a Houston coworking company knew they needed to find a way to reach professionals and entrepreneurs digitally.

Sesh Coworking launched its Inner Circle membership this week to be a one-stop shop for business, connection, support, and more for members. Last month, Meredith Wheeler and Maggie Segrich began working on the virtual space after discovering the need for this virtual space from their network.

"We talked to a lot of people," Wheeler tells InnovationMap. "We were constantly asking people, 'what do you need right now?' And the resounding answer was for community and connection."

While Sesh reopened its physical space in Montrose on June 1, not all members were comfortable — or even able — to return to Sesh in person. So, the idea was to bring Sesh's culture and mission to them by taking the company's existing member portal and upgrading it with features like video conferencing, chatrooms, and more.

"It's almost kind of like a new age version of AIM chat. You could see who's online and you can chat with them," Segrich says. "You can work alongside with people."

With these new tech capabilities, Sesh can continue some of its events — like coffee and coworking and other networking and social events — virtually. Segrich and Wheeler also say they will be able to create accountability groups since some members have said that this new way of working makes it hard to focus and get stuff done.

The platform will also enable educational and training-based events, and Sesh has already created a kind of catalogue for resources and materials that come out of these events so that all members can have access to that information, not just the ones that were able to log on for the event.

"With business right now, and Maggie and I are feeling this constantly, it's like everyday is a new pivot — a new turn, twist, or adaptation that we're having to create," Wheeler says. "Sometimes, you know what you need to do and you don't know how to do it, but you need to figure it out fast. So, hopefully by having these resources at the tips of their fingers, our members can make those turns quicker."

A major perk for Sesh and its founders is that, now that they have everything set up and launched, their reach expands much further than their Sesh Loft in Montrose.

"This is not just limited to Houston. This can go, and we hope it goes, nationwide. We've had folks from all over the country on our digital events," Wheeler says. "This could be the silver lining from everything that's happening in 2020 — that our authentic digital connection has a much farther way to travel."

The first 30 members of Sesh Inner Circle can get a monthly membership rate of just $5.99. After that, it's $14.99 a month to sign up. Existing members to the physical space have access to the virtual platform, and virtual members can access special rates on booking space in the Sesh Loft. The launch of Inner Circle has also corresponded with the expansion of Sesh's store of locally sourced products. The store is available at the Sesh Loft or online.

Connect online

Photo via seshcoworking.com

The member portal lets Sesh coworkers have a one-stop shop for virtual and in-person engagement.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.